Premium
Phenytoin overdose treated with hemodialysis using a high cut‐off dialyzer
Author(s) -
Cormier Monique J.,
Desmeules Simon,
StOnge Maude,
Ghannoum Marc
Publication year - 2017
Publication title -
hemodialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 47
eISSN - 1542-4758
pISSN - 1492-7535
DOI - 10.1111/hdi.12475
Subject(s) - phenytoin , hemodialysis , medicine , albumin , anesthesia , anticonvulsant , pharmacology , surgery , epilepsy , psychiatry
We describe the case of a 52‐year‐old man who presented after having ingested an unknown quantity of phenytoin. Peak phenytoin concentration was 51.2 mg/L (therapeutic range 10–20 mg/L). Five days after admission, the patient became comatose and was intubated. Because of persistent toxic phenytoin levels and unchanged clinical status for 12 days, hemodialysis (HD) was prescribed to enhance elimination of phenytoin. HD was performed using a Gambro Theralite TM filter (Baxter International Inc., Deerfield, USA), a high cut‐off filter that allows the removal of molecules of up to 45 kDa. Phenytoin concentration readily decreased during the 8‐hour HD treatment from 38.9 mg/L to 27.8 mg/L (28.5% decrease); during HD, phenytoin half‐life was 18.5h (compared to 1109.8h before HD and 56.3h after HD), phentyoin clearance averaged 80.1 mL/min and a total of 1.1 g of phenytoin was removed. Albumin removal from the Theralite filter was most important at the beginning of HD. The high clearance of phenytoin obtained with this filter was likely due to its high surface area rather than its capacity to remove the albumin‐phenytoin complex.